210 related articles for article (PubMed ID: 25431204)
1. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology.
Lin XY; Zhang H; Tang N; Zhang XP; Zhang W; Wang EH; Han YC
Histopathology; 2015 Apr; 66(5):685-94. PubMed ID: 25431204
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
Giménez-Bachs JM; Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SH; Rubio-Del Campo A; Sánchez-Prieto R
Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179
[TBL] [Abstract][Full Text] [Related]
3. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
[TBL] [Abstract][Full Text] [Related]
4. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma.
Pantuck AJ; Klatte T; Seligson D; Atkins M; Belldegrun A
J Clin Oncol; 2008 Jun; 26(18):3105-7; author reply 3107-9. PubMed ID: 18565906
[No Abstract] [Full Text] [Related]
7. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
[TBL] [Abstract][Full Text] [Related]
9. Expression of carbonic anhydrase IX in genitourinary and adrenal tumours.
Donato DP; Johnson MT; Yang XJ; Zynger DL
Histopathology; 2011 Dec; 59(6):1229-39. PubMed ID: 22175902
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung.
Ramsey ML; Yuh BJ; Johnson MT; Yeldandi AV; Zynger DL
Virchows Arch; 2012 Jan; 460(1):89-93. PubMed ID: 22143934
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX: a promising diagnostic and prognostic biomarker in breast carcinoma.
Furjelová M; Kovalská M; Jurková K; Horáček J; Carbolová T; Adamkov M
Acta Histochem; 2014 Jan; 116(1):89-93. PubMed ID: 23816158
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
Tostain J; Li G; Gentil-Perret A; Gigante M
Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
[TBL] [Abstract][Full Text] [Related]
14. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma.
Vermylen P; Roufosse C; Burny A; Verhest A; Bosschaerts T; Pastorekova S; Ninane V; Sculier JP
Eur Respir J; 1999 Oct; 14(4):806-11. PubMed ID: 10573225
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase expression in kidney and renal cancer: implications for diagnosis and treatment.
Oosterwijk E
Subcell Biochem; 2014; 75():181-98. PubMed ID: 24146380
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase IX: historical and future perspectives.
Oosterwijk E
BJU Int; 2008 Jun; 101 Suppl 4():2-7. PubMed ID: 18430115
[No Abstract] [Full Text] [Related]
18. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
Alshenawy HA
Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.
Zhang BY; Thompson RH; Lohse CM; Dronca RS; Cheville JC; Kwon ED; Leibovich BC
BJU Int; 2013 Jun; 111(7):1046-53. PubMed ID: 23551810
[TBL] [Abstract][Full Text] [Related]
20. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
Papworth K; Sandlund J; Grankvist K; Ljungberg B; Rasmuson T
Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]